Gradientech expands with senior business development presence in the US
The diagnostics company Gradientech today announces the signing of a long-term agreement with Marc van Nuenen for heading the company’s business development activities in the US including preparation for clinical studies towards an FDA approval of the QuickMIC® system.Marc van Nuenen and Gradientech have agreed on a long-term collaboration to prepare and set up clinical studies and head commercial activities in the US for the rapid antibiotic susceptibility testing system QuickMIC by Gradientech.
“It is my great pleasure to invite Marc to the team. His unparalleled network and his deep